Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mihir Rajesh Ghatalia
- Employees
- 132
- Headquarters
- Mumbai, India
- IPO year
- 2021
- Market cap
- ₹2.6B
- Website
- https://www.aareydrugs.com
Loading AAREYDRUGS…
Loading profile data…Frequently asked questions about AAREYDRUGS
What does Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS) do?
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, bulk drugs, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1,3 dioxalane, uracile and active pharma ingredients, such a...
Where does AAREYDRUGS.NS trade?
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS) trades on the National Stock Exchange of India.
What sector is AAREYDRUGS.NS in?
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aarey Drugs & Pharmaceuticals Limited?
Mihir Rajesh Ghatalia is the chief executive officer of Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS).
Where is Aarey Drugs & Pharmaceuticals Limited headquartered?
Aarey Drugs & Pharmaceuticals Limited is headquartered in India.
Does AAREYDRUGS.NS pay a dividend?
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AAREYDRUGS.NS go public?
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS) completed its initial public offering in 2021.